Claim Missing Document
Check
Articles

Found 2 Documents
Search

Bronchoscopic Balloon Dilatation for Tuberculosis-related Bronchial Stenosis: A Rare Case Wahyuni, Titis Dewi; Alatas, Mohamad Fahmi; Widysanto, Allen; Siahaan, Sylvia Sagita; Muljadi, Rusli; Carolline, Chaifung
Respiratory Science Vol. 4 No. 2 (2024): Respiratory Science
Publisher : Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/respirsci.v4i2.125

Abstract

Background: Bronchial stenosis is known as a complication of endobronchial tuberculosis (EBTB). The incidence of stenosis affects quality of life. A minimally invasive therapeutic strategy, bronchoscopic balloon dilatation (BBD), can be chosen to manage the disease. Case: A 29-year-old woman suffered from bronchial stenosis, which appeared after completing treatment for tuberculosis (TB). She was diagnosed with TB around the middle of her pregnancy. She received anti-tuberculosis treatment for six months. Two years later, she complained of a persistent cough for two weeks prior to hospitalization. A complete stenosis of the left main bronchus with atelectatic on the left lung was seen on a chest CT scan. The result was confirmed with a bronchoscopy procedure. There were no mycobacteria or other suspicious organisms found in bronchial washings. Bronchoscopic balloon dilatation action was successful. Discussion: Endobronchial tuberculosis is a tuberculous infection that affects the tracheobronchial tree. It can be treated with minimally invasive procedures like bronchoscopy or surgical interventions. If the stenosis is mild or moderate, several procedures such as balloon dilatation, stents, laser photoresection, argon plasma coagulation, and cryotherapy are often performed. Bronchoscopy balloon dilatation nowadays has become a more preferred treatment option for tracheal and bronchial stenosis because  it may be areliable and effective method.    Conclusion: The BDD procedure in this patient showed good results. This procedure is fast, easy, safe, minimally invasive, and the symptoms resolve quickly. It can be concluded that BBD is a safe and effective therapy for TB-related bronchial stenosis, but the long-term effects of the procedure remain to be monitored.
A Case Report of a 70-Year-Old Male with Chronic Thromboembolic Pulmonary Hypertension (CTEPH), when to be aware? Chaifung Carolline; Siahaan, Sylvia Sagita; Widysanto, Allen; Wahyuni, Titis Dewi; Wijaya, Victor Nugroho; Sirait, Magdalena; Pradono, Clarissa Moira
Malang Respiratory Journal Vol. 8 No. 1 (2026): Volume 8 No 1, March 2026 Edition
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2026.008.01.06

Abstract

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon disorder that arises as a complication of unresolved pulmonary embolism (PE). Without timely intervention, it poses a substantial risk of increased morbidity and mortality. Case A 70-year-old male was admitted with complaints of shortness of breath and productive cough that had persisted for three days prior to hospitalization. He reported progressive exertional dyspnea over the past six months. On examination, the patient exhibited refractory hypoxemia and jugular venous distention. Diagnostic imaging, including computed tomography pulmonary angiography (CTPA) and a lung perfusion scan, confirmed a diagnosis of CTEPH. Laboratory results revealed an elevated D-dimer level of 18.27 mg/dL. The patient was treated with subcutaneous anticoagulants and oral anticoagulant therapy, resulting in clinical improvement. Upon discharge, he was prescribed pulmonary vasodilators and lifelong anticoagulation therapy to maintain his condition. Conclusion Pulmonary vascular disease should be considered as a differential diagnosis in patients with unexplained dyspnea. CTPA is recommended as a diagnostic modality for confirming CTEPH. Lifelong anticoagulation is essential in managing CTEPH, with the primary treatment goals being the restoration of normal pulmonary blood flow, reducing the workload on the right ventricle, and preventing or addressing small vessel disease. Keywords chronic thromboembolic pulmonary hypertension, oral anticoagulant, Computed Tomography Pulmonary Angiography